Cilazapril

Cilazapril Basic information
Product Name:Cilazapril
Synonyms:6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-, (1S,9S)-;6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-, [1S-[1α,9α(R*)]]-;Ro 31-2848;Yipingshu;CILASTATIN NA;CILASTATIN SODIUM SALT;sodium hydrogen 7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate;(1S,9S)-9-[(S)-1-Ethoxycarbonyl-3-phenylpropylamino]-10-oxoperhydropyridazino[1,2-a][1,2]diazepine-1-carboxylic acid
CAS:88768-40-5
MF:C22H31N3O5
MW:417.5
EINECS:641-006-9
Product Categories:Chiral Reagents;API;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:88768-40-5.mol
Cilazapril Structure
Cilazapril Chemical Properties
Melting point 95-97°C
Boiling point 598.1±60.0 °C(Predicted)
density 1.26±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility Chloroform (Slightly), Ethanol (Slightly, Sonicated), Methanol (Slightly)
form powder
pka2.28±0.20(Predicted)
color White to Off-White
CAS DataBase Reference88768-40-5(CAS DataBase Reference)
Safety Information
Safety Statements 22-24/25
WGK Germany 3
RTECS MJ9650200
MSDS Information
Cilazapril Usage And Synthesis
DescriptionCilazapril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor cilazaprilat. In vivo, cilazapril (0.1 mg/kg) inhibits plasma ACE activity and inhibits the angiotensin I-induced pressor response in anesthetized rats and cats. It decreases systolic blood pressure in spontaneously hypertensive rats when administered at a dose of 30 mg/kg. Cilazapril (10 mg/kg, p.o.) decreases blood pressure in volume-depleted renal hypertensive dogs. Formulations containing cilazapril have been used in the treatment of hypertension.
Chemical PropertiesOff-White Solid
UsesAn ACE inhibitor. Hydrolyzed in vivo to the active diacid metabolite (Cilazaprilat). Antihypertensive.
DefinitionChEBI: Cilazapril is a pyridazinodiazepine resulting from the formal condensation of the carboxy group of cilazaprilat with ethanol. It is a drug used in the treatment of hypertension and heart failure. It has a role as a prodrug, an antihypertensive agent and an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor. It is an ethyl ester, a pyridazinodiazepine and a dicarboxylic acid monoester. It is functionally related to a Cilazaprilat.
Brand nameInhibace (Hoffmann-LaRoche).
Cilazapril Preparation Products And Raw materials
CILAZAPRIL EPC(CRM STANDARD),CILAZAPRIL EPC( 1,1-DIBUTYLHYDRAZINE DELAPRIL Carbonyl iron powder Cilazapril(U.D.) L-Homophenylalanine ethyl ester CILAZAPRIL CILAZAPRIL IMPURITY D Ethyl N-(2-butyl)glycinate L-β-Homophenylalanine, HPLC 98% 2,2'-(ETHYLENEDIIMINO)-DIBUTYRIC ACID Cilazaprilat NITROUS OXIDE Cilastatin sodium DIAZOXIDE CILAZAPRIL IMPURITY A Cilazapril HEXAHYDROPYRIDAZINE-3-CARBOXYLIC ACID

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.